Substance / Medication

Baloxavir

Overview

Active Ingredient
baloxavir
RxNorm CUI
2197842

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Rapid health technology assessment of the novel endonuclease inhibitor baloxavir for the treatment of influenza.
Huang Guangliang, Tian Yunfei, Cui Wenyan et al. · J Chemother · 2024
PMID: 37767970Meta-Analysis
Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials.
Kuo Yu-Chi, Lai Chih-Cheng, Wang Ya-Hui et al. · J Microbiol Immunol Infect · 2021
PMID: 34020891Meta-Analysis
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza.
Monto Arnold S, Kuhlbusch Klaus, Bernasconi Corrado et al. · N Engl J Med · 2025
PMID: 40267424RCT

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Baloxavir (substance)
SNOMED CT
797928000
UMLS CUI
C4734224
RxNorm CUI
2197842

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.